97 filings
Page 3 of 5
EFFECT
zh0dekl4sq frzakz
1 May 23
Notice of effectiveness
12:15am
10-K/A
svyt510z fb31buu4y9
28 Apr 23
Annual report (amended)
4:15pm
8-K
78k0ugh38fbwpmc0d
26 Apr 23
Entry into a Material Definitive Agreement
8:30am
8-K
iwz8 ljp4o
18 Apr 23
ZW191 demonstrates strong responses in FRĪ±-low expressing patient-derived xenograft (PDX) models with favorable pharmacokinetic and safety profiles
4:18pm
8-K
kkznxy7
10 Apr 23
Zymeworks Announces Appointment of Derek J. Miller to its Board of Directors
4:46pm
8-K
3wm cw1igbqqvyrfo9l
17 Mar 23
Termination of a Material Definitive Agreement
4:16pm
8-K
dv2yll
15 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
S-8
409zt
7 Mar 23
Registration of securities for employees
5:23pm
POS AM
ikddec1svrh5w78
7 Mar 23
Prospectus update (post-effective amendment)
5:20pm
10-K
5pw0guynvxpq 6x5
7 Mar 23
Annual report
4:38pm
POSASR
vurmymf7o1bfs4px q1
7 Mar 23
Automatic shelf registration (post-effective amendment)
4:17pm
8-K
9jm5rgraqebeen
7 Mar 23
Zymeworks Reports Fourth Quarter and Full Year 2022 Financial Results
4:06pm
8-K
t8mz97
19 Jan 23
Other Events
8:11am
8-K
yz5c762p
4 Jan 23
Zymeworks Provides Corporate Update on Key Strategic Priorities and Outlook for 2023
4:21pm
8-K
nv3lcogjue 2zrr9id
30 Dec 22
Departure of Directors or Certain Officers
4:31pm
8-K
lbcrc hl4d9qyde8t9
21 Dec 22
Jazz Pharmaceuticals and Zymeworks Announce Jazz has Confirmed Opt-in and Advances Partnership for Zanidatamab
8:37am
8-K
2l5jx41xq4noucq qq8s
19 Dec 22
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
zglgp6
19 Dec 22
Zymeworks Announces Positive Topline Data in the Pivotal HERIZON-BTC-01 Trial of Zanidatamab
7:15am
CERT
rmz5s0 1zvwa2ez
15 Dec 22
Certification of approval for exchange listing
5:13pm